Literature DB >> 19193832

Novel method for determination of substance P levels in unextracted human plasma by using acidification.

Donald E Campbell1, Paula Bruckner, Nancy B Tustin, Richard Tustin, Steven D Douglas.   

Abstract

Substance P (SP) is a member of the tachykinin family and has an important role in immune responses. SP is detectable in plasma in a free and bound state. Simple modification of a commercially available SP enzyme-linked immunosorbent assay allows the dissociation and capture of plasma SP without solid-phase extraction.

Entities:  

Mesh：

Substances：

Year:  2009        PMID： 19193832      PMCID： PMC2668282          DOI： 10.1128/CVI.00406-08

Source DB:  PubMed          Journal:  Clin Vaccine Immunol        ISSN： 1556-679X


  27 in total

Review 1.  Putative peptide neurotransmitters.

Authors:  M Otsuka; T Takahashi
Journal:  Annu Rev Pharmacol Toxicol       Date:  1977       Impact factor: 13.820

Review 2.  Tachykinin-mediated modulation of the immune response.

Authors:  Kenneth L Bost
Journal:  Front Biosci       Date:  2004-09-01

3.  Increased expression of preprotachykinin-I and neurokinin receptors in human breast cancer cells: implications for bone marrow metastasis.

Authors:  D Singh; D D Joshi; M Hameed; J Qian; P Gascón; P B Maloof; A Mosenthal; P Rameshwar
Journal:  Proc Natl Acad Sci U S A       Date:  2000-01-04       Impact factor: 11.205

Review 4.  Substance P as a transmitter candidate.

Authors:  R A Nicoll; C Schenker; S E Leeman
Journal:  Annu Rev Neurosci       Date:  1980       Impact factor: 12.449

5.  Substance P receptor expression on lymphocytes is associated with the immune response to respiratory syncytial virus infection.

Authors:  Ralph A Tripp; Albert Barskey; Laura Goss; Larry J Anderson
Journal:  J Neuroimmunol       Date:  2002-08       Impact factor: 3.478

6.  Substance P serum levels are increased in major depression: preliminary results.

Authors:  Brigitta Bondy; Thomas C Baghai; Christo Minov; Cornelius Schüle; Markus J Schwarz; Peter Zwanzger; Rainer Rupprecht; Hans J ürgen Möller
Journal:  Biol Psychiatry       Date:  2003-03-15       Impact factor: 13.382

7.  Elevated substance P levels in HIV-infected men.

Authors:  S D Douglas; W Z Ho; D R Gettes; A Cnaan; H Zhao; J Leserman; J M Petitto; R N Golden; D L Evans
Journal:  AIDS       Date:  2001-10-19       Impact factor: 4.177

8.  Evidence of decreased plasma substance P levels in human essential hypertension and influence of prazosin treatment.

Authors:  H D Faulhaber; R Rathsack; G Rostock; V Homuth; D Pfeiffer; E Naumann; W Hartrodt; R C Görne; P Oehme
Journal:  Biomed Biochim Acta       Date:  1983

Review 9.  New insights into the antidepressant actions of substance P (NK1 receptor) antagonists.

Authors:  Nadia M J Rupniak
Journal:  Can J Physiol Pharmacol       Date:  2002-05       Impact factor: 2.273

10.  Elevated substance P levels in HIV-infected women in comparison to HIV-negative women.

Authors:  Steven D Douglas; Avital Cnaan; Kevin G Lynch; Tami Benton; Huaqing Zhao; David R Gettes; Dwight L Evans
Journal:  AIDS Res Hum Retroviruses       Date:  2008-03       Impact factor: 2.205
View more
  4 in total

1.  Dexmedetomidine combined with interscalene brachial plexus block has a synergistic effect on relieving postoperative pain after arthroscopic rotator cuff repair.

Authors:  Jung-Taek Hwang; Ji Su Jang; Jae Jun Lee; Dong-Keun Song; Han Na Lee; Do-Young Kim; Sang-Soo Lee; Sung Mi Hwang; Yong-Been Kim; Sanghyeon Lee
Journal:  Knee Surg Sports Traumatol Arthrosc       Date:  2019-11-26       Impact factor: 4.342

2.  Expression of substance P, neurokinin-1 receptor and immune markers in the brains of individuals with HIV-associated neuropathology.

Authors:  Sergei Spitsin; Kathleen E Stevens; Steven D Douglas
Journal:  J Neurol Sci       Date:  2013-08-02       Impact factor: 3.181

3.  A randomized, placebo controlled, double masked phase IB study evaluating the safety and antiviral activity of aprepitant, a neurokinin-1 receptor antagonist in HIV-1 infected adults.

Authors:  Pablo Tebas; Florin Tuluc; Jeffrey S Barrett; Wayne Wagner; Deborah Kim; Huaquing Zhao; René Gonin; James Korelitz; Steven D Douglas
Journal:  PLoS One       Date:  2011-09-08       Impact factor: 3.240

4.  Reduction of soluble CD163, substance P, programmed death 1 and inflammatory markers: phase 1B trial of aprepitant in HIV-1-infected adults.

Authors:  Pablo Tebas; Sergei Spitsin; Jeffrey S Barrett; Florin Tuluc; Okan Elci; James J Korelitz; Wayne Wagner; Angela Winters; Deborah Kim; Renae Catalano; Dwight L Evans; Steven D Douglas
Journal:  AIDS       Date:  2015-05-15       Impact factor: 4.177
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.